Clinical trial

A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study

NCT01230853

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-08-01

PhasePHASE1

Study timeline

Study start (unknown)2010-08-01Date precision: month

Registry last updated2020-11-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer's Diseaseverified · MONDO: Alzheimer disease

Interventions

Active Comparator: ADRUG

Placebo Comparator BDRUG

Active Comparator BDRUG

Placebo Comparator ADRUG

Sponsors & collaborators

Eisai Inc.lead sponsor

Mapped research locations

AtlantaGeorgia, United States1 San FranciscoCalifornia, United States1 IndianapolisIndiana, United States1 OrlandoFlorida, United States1 Salt Lake CityUtah, United States1 Garden GroveCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01230853 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.